Literature DB >> 2201261

Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

D V Milford1, C M Taylor, B Guttridge, S M Hall, B Rowe, H Kleanthous.   

Abstract

A prospective study of the clinical and epidemiological features of the haemolytic uraemic syndromes was conducted over a three year period in the British Isles. Two hundred and ninety eight children were reported. In two thirds of cases stool samples were analysed for the presence of Verocytotoxin producing Escherichia coli (VTEC) and neutralisable Verocytotoxin. A total of 273 (95%) patients had a prodrome of diarrhoea. In these a seasonal variation in the incidence of haemolytic uraemic syndrome was demonstrated, the 1-2 year age range was most often affected, and the peripheral blood neutrophil count correlated positively with an adverse outcome. Patients presenting without diarrhoea showed none of these associations and had a significantly greater morbidity and mortality. Evidence for VTEC infection was found in 58 (33%) of 178 diarrhoea associated cases whose stools were analysed, although VTEC were identified in five of eight (62%) patients whose stools were collected within three days of the onset of diarrhoea. Most isolates produced VT2 either alone, or together with VT1. There was no evidence of VTEC infection in patients without prodromal diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201261      PMCID: PMC1792437          DOI: 10.1136/adc.65.7.716

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  The British Paediatric Surveillance Unit.

Authors:  S M Hall; M Glickman
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

2.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

Authors:  C M Taylor; R H White; M H Winterborn; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

3.  Risk factors for development of hemolytic uremic syndrome during shigellosis.

Authors:  T Butler; M R Islam; M A Azad; P K Jones
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

4.  Dilated cardiomyopathy associated with haemolytic uraemic syndrome.

Authors:  J Poulton; C M Taylor; J V De Giovanni
Journal:  Br Heart J       Date:  1987-02

5.  Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland.

Authors:  J S Kinney; T P Gross; C C Porter; M F Rogers; L B Schonberger; E S Hurwitz
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

6.  A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

Authors:  M F Rogers; G W Rutherford; S R Alexander; J H DiLiberti; L Foster; L B Schonberger; E S Hurwitz
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

7.  Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.

Authors:  M A Neill; P I Tarr; C R Clausen; D L Christie; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

8.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  64 in total

1.  Haemolytic uraemic syndrome and E coli O157.

Authors:  M Fitzpatrick
Journal:  BMJ       Date:  1999-03-13

2.  Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Authors:  Abhineet S Sheoran; Igor P Dmitriev; Elena A Kashentseva; Ocean Cohen; Jean Mukherjee; Michelle Debatis; Jonathan Shearer; Jacqueline M Tremblay; Gillian Beamer; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

3.  Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.

Authors:  Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-12-13       Impact factor: 3.714

Review 4.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  A plea for standardized terminology within the haemolytic uraemic syndromes.

Authors:  C M Taylor; D V Milford; R H White
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

9.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome?

Authors:  Rachel Harwood; David Wilkinson; Shweta Ramkumar; Gillian Humphrey
Journal:  Pediatr Surg Int       Date:  2015-11-17       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.